Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February

Rhea-AI Summary

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leader in regenerative medicine, will participate in two upcoming investor conferences. Management will engage in a virtual fireside chat on February 16 at 1:30 p.m. ET during the BTIG Virtual MedTech Conference. Additionally, they will partake in another virtual chat on February 18 at 8:40 a.m. ET for the 11th Annual SVB Leerink Global Healthcare Conference. Live webcasts will be accessible via the respective conference websites, with the second's archive available for 30 days post-event.

CANTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in the following upcoming investor conferences:

The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

• Management will participate in a virtual fireside chat on Wednesday, February 16 at 1:30 p.m. Eastern Time. A webcast of the fireside chat will be available to BTIG clients attending the conference via the conference website. To listen to the live event, please contact your BTIG representative.
  

The 11th Annual SVB Leerink Global Healthcare Conference

• Management will participate in a virtual fireside chat on Friday, February 18 at 8:40 a.m. Eastern Time. A live webcast of the fireside chat will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.

About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.

FAQ

What is the date of Organogenesis's participation in the BTIG conference?

Organogenesis will participate in the BTIG Virtual MedTech Conference on February 16, 2022.

What time will Organogenesis's fireside chat occur at the SVB Leerink Global Healthcare Conference?

The fireside chat at the SVB Leerink Global Healthcare Conference will take place on February 18, 2022, at 8:40 a.m. ET.

How can investors access the live webcast for Organogenesis's chats?

Investors can access the live webcast for the BTIG conference via the conference website and for the SVB Leerink conference through the Investor Relations page on Organogenesis's website.

Will there be a replay available for Organogenesis's events?

Yes, an archive of the fireside chat from the SVB Leerink conference will be available for replay for approximately 30 days after the event.

What does Organogenesis specialize in?

Organogenesis specializes in regenerative medicine, focusing on advanced wound care and surgical and sports medicine solutions.